Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novint Technologies is a haptic technology company that specializes in the development of 3D touch interfaces for medical, industrial, and consumer applications. The company's flagship product, the Novint Falcon, provides high-resolution force feedback, allowing users to 'feel' virtual objects with realistic weight, shape, and texture. In the healthcare domain, Novint's technology has been integrated into surgical simulation platforms and medical training modules to improve practitioner dexterity and procedural accuracy. The company has also investigated the use of its haptic devices in neurorehabilitation to assist patients recovering from motor impairments. Its technology originated from research at Sandia National Laboratories and has been utilized in various clinical research settings for telerehabilitation. Although a pioneer in the field of accessible haptics, the company has seen a significant decline in commercial operations in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novint Technologies.